[ad_1]
According to new data on US Primary Health Care (PCP) perceptions about InCrowd's influenza vaccine, the inventor of seasonal influenza vaccine has risen to the highest level in 2018 in 2018 from real-time business information form for the life sciences.
On this, the 100th In the year of the 1918 influenza pandemic, where about 50 million people died in the decades leading up to the development of an influenza vaccine, the InCrowds findings suggest that we We must continue the public awareness campaign on the benefits of the flu shot, at the risk of experiencing another global health crisis. Diane Hayes, Ph.D., epidemiologist and co-founder of InCrowd who led the micro-survey.
The annual five-minute microsurvey monitors the perceptions of US PCPs who administer the influenza vaccine for reasons of non-vaccination of their patients, where patients are vaccinated against influenza, to doctors' reflections on the advantages and disadvantages of vaccinations in hospitals. pharmacies and grocery stores, as well as clinic requirements for vaccination. staff vaccinations.
While the majority of patients consent to an influenza vaccine, 79% of 201851% of PCP respondents this year report misconceptions about the risks and benefits of influenza vaccines, up from 44% in 2017 and 2016.
Most people need to be reassured that the flu vaccine will not cause them the flu, said a Tennessee PCP. The second most important reason why patients refuse to be vaccinated against the flu is that they do not get sick or never contract the flu, at 32% this year. Although anti-vaccination sentiment was invoked as the reason, only 6% noted it in 2018.
The micro-survey on PCP perception also revealed that:
- A little more patients (61%) will receive the influenza vaccine in their doctor's office, compared to 57% in 2017 and 55% in 2016.
- Eighteen percent of patients will be vaccinated at a pharmacy or grocery store.
- Thirty-seven per cent of PCPs remain concerned that influenza vaccines administered by pharmacies or grocery stores are not on the patient's medical file, although several textual remarks indicated that the respondent State had imposed a universal vaccination record.
- A joint mini-survey of pharmacists who administer influenza vaccines suggests to physicians that medical records indicating their patients, indicating that the influenza vaccine of their patients might be well-founded, are well-founded. Forty-two percent of pharmacists who administered influenza vaccines said their clinic did not provide a medical record of vaccines injected directly into the PCP, while 42% said their clinic automated faxing to patients PCP as a record of an influenza vaccine, and 16% were connecting. directly to the medical file.
- Although 43% of PCPs in 2018 report that the availability of influenza vaccine in pharmacies or grocery stores makes it easier for their patients to access, 13% believe that these clinics offer no major benefit, compared with only 2% in 2017 (2%) and 7% in 2016
- Nine out of 10 respondents indicated that their clinics require all staff members to receive an annual influenza vaccine. Clinics that do not explicitly require vaccination often still strongly encourage it, which can have negative consequences for non-compliance, including dismissal for lack of justification, according to one respondent.
The 5-minute micro-survey of physicians' perceptions of the influenza vaccine included data from 201 PCP influenza vaccine. It resulted in a response between October 23 and 25, 2018. The supplementary micro-survey of pharmacists administering the influenza vaccine included 50 pharmacists who responded on November 16, 2018.
For more information on InCrowd's research, please contact InCrowd.
About InCrowd InCrowd pioneered a real-time mobile MicroSurvey solution, providing US life sciences companies with the best agile and primary market research. InCrowd has access to 1.8 million health professionals worldwide in 20 languages. Serving more than 200 brands, InCrowd accelerates market research and helps customers market their products faster.
Meghan Oates-Zalesky
Senior Vice President of Marketing
[email protected]
617-435-2470
Mary Kae Marinac
Representative PR InCrowd
[email protected]
978-685-3136
Source link
